301. 209 Large Offspring Syndrome: Effects of in vitro Production on Embryo Epigenetics and Development
- Author
-
Rocío Melissa Rivera
- Subjects
Andrology ,Offspring ,Genetics ,Oral Presentations ,Animal Science and Zoology ,Embryo ,General Medicine ,Epigenetics ,Biology ,In vitro ,Food Science - Abstract
In cattle, the use of assisted reproductive technologies (ART) can result in a congenital overgrowth condition known as large/abnormal offspring syndrome (LOS/AOS). The phenotypic characteristics of LOS include; somatic overgrowth, abdominal wall defects, large organs, breathing difficulties, skeletal defects, hypoglycemia, abnormal placentas, difficulty suckling, and perinatal death. LOS can have detrimental effects on the offspring and dam and also pose managerial and financial challenges to the producer. Research from the Rivera laboratory has demonstrated that LOS is an epigenetic syndrome. As in cattle, ART can promote the development of congenital overgrowth in humans, a condition known as Beckwith Wiedemann Syndrome (BWS). For the past 13 years, the Rivera laboratory has been characterizing LOS and we have shown that LOS and BWS are phenotypically and epigenotypically similar. In our studies, using gestation day ~105 Bos taurus taurus x Bos taurus indicus F1 hybrids, we showed global misregulation of imprinted and non-imprinted transcripts, micro RNAs and global misregulation of DNA methylation. In brief, LOS fetuses displayed variable loss-of-imprinting in kidney, liver, muscle and brain, when compared to controls. Biallelic expression of imprinted genes in LOS was associated with tissue-specific hypomethylation of the normally methylated parental allele. Not only was there loss of allele-specific expression of imprinted genes in LOS, but we also observed differential transcript amounts of these genes between control and overgrown fetuses. In addition, a positive correlation was observed between bodyweight and the number of biallelically expressed imprinted genes in LOS fetuses. From this work, we concluded that LOS is a multi-locus loss-of-imprinting condition. Current work, aims to determine if LOS is identifiable during pregnancy using day 55 fetal ultrasonography and day 55 and 105 maternal blood. In addition, we aim to determine how serum supplementation of culture medium can program preimplantation embryos to develop LOS. Findings will be discussed.
- Published
- 2021